Transport of cis- and trans-4-[(18)F]fluoro-L-proline in F98 glioma cells

Nucl Med Biol. 2002 Aug;29(6):685-92. doi: 10.1016/s0969-8051(02)00327-x.

Abstract

The transport mechanisms of cis-4-[(18)F]fluoro-L-proline (cis-FPro) and trans-4-[(18)F]fluoro-L-proline (trans-FPro) were studied in F98 rat glioma cells in comparison to the natural parent [(3)H]-L-proline. Uptake rates of cis-FPro and trans-FPro in F98 glioma cells were 50-70% lower than those of [(3)H]-L-proline. The amino transport system A inhibitor MeAIB reduced the uptake of [(3)H]-L-proline by 30% and uptake of cis-FPro by 46% while uptake of trans-FPro was not significantly changed. BCH inhibited the uptake of all tracers by 35-44%, serine by 70-90% and L-proline by 60 -80%. Absence of Na(+) reduced uptake of all tracers significantly but no further inhibitory effect could be observed which suggests a component of unspecific uptake. Radioactivity of cis- and trans-FPro in the acid precipitable fraction was < 1% after 120 min incubation time while [(3)H]-L-proline exhibited a 20% incorporation into protein. Whole body PET scans in humans demonstrated a retention of cis-FPro in the renal cortex, liver and the pancreas while trans-FPro was retained particularly in muscles. We conclude that system A amino acid transport appears to be selectively relevant for cis-FPro which may contribute to the observed differences in whole body distribution of cis-FPro and trans-FPro in humans.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abdomen / diagnostic imaging
  • Adult
  • Animals
  • Back / diagnostic imaging
  • Biological Transport, Active
  • Female
  • Glioma / diagnostic imaging
  • Glioma / metabolism*
  • Humans
  • Proline / analogs & derivatives
  • Proline / pharmacokinetics*
  • Radiopharmaceuticals
  • Rats
  • Reference Values
  • Sensitivity and Specificity
  • Thorax / diagnostic imaging
  • Thorax / metabolism
  • Tissue Distribution
  • Tomography, Emission-Computed
  • Tumor Cells, Cultured
  • Whole-Body Counting

Substances

  • Radiopharmaceuticals
  • fluoro-proline
  • Proline